Office for the Advancement of Developing Industries: Difference between revisions

From Bhamwiki
Jump to navigation Jump to search
(New page: The '''Office for the Advancement of Developing Industries''' ('''OADI''') is an business incubator operated by UAB with a focus on medical and biotechnological research and developmen...)
 
No edit summary
Line 1: Line 1:
The '''Office for the Advancement of Developing Industries''' ('''OADI''') is an business incubator operated by [[UAB]] with a focus on medical and biotechnological research and development. It was founded in [[1997]] in a 68,500 square-foot building in the [[UAB Research Park]] in [[Oxmoor]].
The '''Office for the Advancement of Developing Industries''' ('''OADI''') is an business incubator operated by [[UAB]] with a focus on medical and biotechnological research and development. It was founded in [[1997]] in a 68,500 square-foot building in the [[UAB Research Park]] in [[Oxmoor]].


In [[2007]] OADI will relocate to the [[Innovation Depot]] in downtown [[Birmingham]] along with the [[Entrepreneurial Center]]. The 1997 building has been put on the market with an asking price of $10 million.
In [[2007]] OADI relocated to the [[Innovation Depot]] in downtown [[Birmingham]] along with the [[Entrepreneurial Center]]. The 1997 building has been put on the market with an asking price of $10 million. It was thought to have been a leading contender for a new influenza vaccine manufacturing plant planned by Solvay Pharmaceuticals. Solvay decided not to build a plant, however.


==References==
==References==

Revision as of 18:00, 30 September 2008

The Office for the Advancement of Developing Industries (OADI) is an business incubator operated by UAB with a focus on medical and biotechnological research and development. It was founded in 1997 in a 68,500 square-foot building in the UAB Research Park in Oxmoor.

In 2007 OADI relocated to the Innovation Depot in downtown Birmingham along with the Entrepreneurial Center. The 1997 building has been put on the market with an asking price of $10 million. It was thought to have been a leading contender for a new influenza vaccine manufacturing plant planned by Solvay Pharmaceuticals. Solvay decided not to build a plant, however.

References

  • Kent, Dawn (March 1, 2007) "Southpace hired to sell building." Birmingham News.

External links